1. What is new in myocardial ischemia? President's opening remarks

   BriefCommunication Pages: 765 - 766

2. Ischemia, reperfusion, and the determinants of tissue injury

   • David J. Hearse

   OriginalPaper Pages: 767 - 776

3. Myocardial ischemia—Metabolic pathways and implications of increased glycolysis

   • Lionel H. Opie

   OriginalPaper Pages: 777 - 790

4. Evolution of free radical formation during low-flow ischemia and reperfusion in isolated rat heart

   • V. Maupoil
   • L. Rochette
   • C. Harpey

   OriginalPaper Pages: 791 - 795

5. Perioperative assessment of the quality of myocardial protection

   • Jean-Noël Fabiani
   • Victor Jebara
   • Alain Carpentier

   OriginalPaper Pages: 797 - 803

6. Trimetazidine: Effects on delayed afterdepolarizations (DADs) and upstroke velocity of the action potential

   • W. A. Coetzee
   • R. Enous
   • L. H. Opie

   Poster Presentations Pages: 806 - 807

7. Antiischemic effect of trimetazidine: Enzymatic and electric response in a model of in-vitro myocardial ischemia

   • C. Libersa
   • E. Honoré
   • B. Dupuis

   Poster Presentations Pages: 808 - 809

8. Electrocardiographic assessment of trimetazidine antiischemic properties

   • P. D'Alché

   Poster Presentations Pages: 810 - 811

9. Antiischemic effects of trimetazidine: ³¹P-NMR spectroscopy study in the isolated rat heart

   • A. Rossi
   • N. Lavanchy
   • J. Martin

   Poster Presentations Pages: 812 - 813

10. Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle

    • C. Guarnieri
    • C. Muscari

    Poster Presentations Pages: 814 - 815

11. Influence of trimetazidine on deleterious effect of oxygen radical species in post-ischemic acute renal failure in the rat

    • P. Catroux
    • N. Benchekroun
    • J. Cambar

    Poster Presentations Pages: 816 - 817

12. Trimetazidine protects the human red blood cell aganst oxygen free radical damage

    • I. Maridonneau-Parini
    • C. Harpey

    Poster Presentations Pages: 818 - 819

13. Acute effects of trimetazidine on ergometric parameters in effort angina

    • P. Sellier
    • C. Harpey
    • P. Ourbak

    Poster Presentations Pages: 820 - 821

14. Chronic effects of trimetazidine on ergometric parameters in effort angina

    • P. Sellier

    Poster Presentations Pages: 822 - 823

15. Combination of trimetazidine with nifedipine in effort angina

    • C. Monpère
    • M. Brochier
    • J.F. Warin

    Poster Presentations Pages: 824 - 825

16. Mechanisms of myocardial ischemia

    • Attilio Maseri

    Poster Presentations Pages: 827 - 831

17. Total ischemic burden in patients with coronary artery disease

    • John Eric Deanfield

    Poster Presentations Pages: 833 - 839

18. A new semiautomated algorithm to quantify holter-detected myocardial ischemia: Preliminary experience in the trimetazidine european multicenter trial (TEMS)

    • Jean-Marie Detry
    • Robert Fester
    • Philippe Leclercq

    Poster Presentations Pages: 841 - 846

19. Imaging of myocardial metabolism by positron emission tomography

    • Pierre Rigo
    • Christian De Landsheere
    • Henri Kulbertus

    Poster Presentations Pages: 847 - 851

20. Comparison of trimetazidine with nifedipine in effort angina: A double-blind, crossover study

    • Sergio Dalla-Volta
    • Giuseppe Maraglino
    • Alessandro Desideri

    Poster Presentations Pages: 853 - 859

21. Cardioprotective effect of trimetazidine in severe ischemic cardiomyopathy

    • H. Bricaud
    • L. Brattier
    • J. Bonnet

    Poster Presentations Pages: 861 - 865